KAINOS Laboratories, Inc. (TYO:4556)

Japan flag Japan · Delayed Price · Currency is JPY
2,277.00
+1.00 (0.04%)
Mar 10, 2026, 3:30 PM JST
81.43%
Market Cap 10.13B
Revenue (ttm) 4.44B
Net Income (ttm) 82.76M
Shares Out 4.45M
EPS (ttm) 18.58
PE Ratio 122.53
Forward PE n/a
Dividend 35.00 (1.54%)
Ex-Dividend Date Mar 28, 2025
Volume 18,200
Average Volume 43,415
Open 2,279.00
Previous Close 2,277.00
Day's Range 2,277.00 - 2,280.00
52-Week Range 1,035.00 - 2,280.00
Beta 0.59
RSI 93.66
Earnings Date May 8, 2026

About KAINOS Laboratories

KAINOS Laboratories, Inc. engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products in Japan. It is also involved in the development, manufacture, marketing, distribution, and import/export of physical and chemical measurement instruments, and medical supplies, as well as nutrition supplements, foodstuff, animal feed, and related products. The company provides various biochemical clinical testing reagents systems, such as Aqua-auto Kainos CRE-IV Tes... [Read more]

Sector Healthcare
Founded 1975
Employees 133
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4556
Full Company Profile

Financial Performance

In fiscal year 2010, KAINOS Laboratories's revenue was 4.22 billion, an increase of 17.25% compared to the previous year's 3.59 billion. Earnings were 101.44 million, a decrease of -39.52%.

Financial Statements

News

There is no news available yet.